Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G de Luca

Showing results (371-380 of 375) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 375 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2020
Informing MS patients on treatment options: a consensus on the process of consent takingC Tortorella, C Solaro, P Annovazzi, et al.
International Journal of Immunopathology and Pharmacology|July 10, 2014
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in ItalyR Totaro, A Lugaresi, P Bellantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 7, 2022
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders registerRoberto Bergamaschi, Ettore Beghi, Cristina Bosetti, et al.
Pageof 38

Showing results (371-380 of 375) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 375 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2020
Informing MS patients on treatment options: a consensus on the process of consent takingC Tortorella, C Solaro, P Annovazzi, et al.
International Journal of Immunopathology and Pharmacology|July 10, 2014
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in ItalyR Totaro, A Lugaresi, P Bellantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 7, 2022
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders registerRoberto Bergamaschi, Ettore Beghi, Cristina Bosetti, et al.
Pageof 38